This tiny biotech stock has finally been approved its Phase 1/2a stem cell trial for Parkinson’s disease, and we are about to see the company’s future tested in real time.
The post This Company Gains a BIG Approval appeared first on Agora Financial.
↧
This Company Gains a BIG Approval
↧